Related Experiment Video
Updated: Jan 29, 2026

Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
American Heart Association 2018 Scientific Sessions
Insights
This summary covers key cardiovascular research, including the effects of dapagliflozin on heart events and new insights into heart failure treatments. It highlights findings on anticoagulation and heart failure therapy withdrawal.
Area of Science:
- Cardiovascular Medicine
- Clinical Cardiology
- Pharmacology
Background:
- Heart failure remains a significant cause of morbidity and mortality worldwide.
- Optimizing pharmacological therapies and understanding treatment withdrawal are critical.
- Advances in anticoagulation and novel drug classes offer new therapeutic avenues.
Purpose of the Study:
- To present pivotal trial results and expert discussions from a major cardiology conference.
- To evaluate the impact of specific drug classes on cardiovascular outcomes.
- To explore strategies for managing heart failure and associated thromboembolic risks.
Main Methods:
- Review of presented clinical trial data and scientific sessions.
- Analysis of pharmacological interventions including SGLT2 inhibitors and ARNI.
- Examination of anticoagulation strategies in specific patient populations.
Main Results:
- Dapagliflozin demonstrated effects on cardiovascular events.
- Angiotensin receptor-neprilysin inhibition showed promise in acute decompensated heart failure.
- Rivaroxaban's impact on thromboembolic events was assessed in heart failure patients.
Conclusions:
- Current research underscores the importance of novel agents in cardiovascular disease management.
- Evidence supports tailored pharmacological approaches for heart failure.
- Further investigation into treatment withdrawal in recovered conditions is warranted.
Abstract:
We report on sessions on the dapagliflozin effect on cardiovascular events; angiotensin receptor-neprilysin inhibition for acute decompensated heart failure; rivaroxaban's effect on thromboembolic events with heart failure, sinus rhythm, and coronary disease; trial results on the withdrawal of pharmacological heart failure therapy in recovered dilated cardiomyopathy; and more from AHA's November meeting.
Related Concept Videos
The Scientific Method
The Scientific Method
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
The Scientific Method
Scientific Laws and Theories
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...

